- Open Access
Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
Cardiovascular Diabetology volume 14, Article number: 128 (2015)
- The original article was published in Cardiovascular Diabetology 2015 14:31
Erratum to: Cardiovascular Diabetology (2015) 14:31 DOI 10.1186/s12933-015-0195-2
After publication of the original article, it came to our attention that the samples used for the MMPs and TIMP-1 measurements were serum samples instead of plasma samples. Therefore,
Plasma levels of MMPs and TIMP-1 in the title, abstract, methods, results and discussion section should read serum levels; and
In the discussion section the sentence, “Possibly the serum measurement does not truly reflect the circulating concentration of MMPs and TIMPs compared to the plasma measurement” should be disregarded.
We apologize for any inconvenience.
The online version of the original article can be found under doi:10.1186/s12933-015-0195-2.
About this article
Cite this article
Peeters, S.A., Engelen, L., Buijs, J. et al. Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Cardiovasc Diabetol 14, 128 (2015). https://doi.org/10.1186/s12933-015-0290-4